CA-AG v. Boston Scientific Corporation

Boston Scientific Corporation allegedly deceptively marketed transvaginal surgical mesh devices to patients. According to CA-AG, Boston misrepresented the safety of these products by failing to disclose the full range of potential serious and irreversible complications caused by mesh, including chronic pain, voiding dysfunction, and new onset of incontinence.

Summary generated from official California Attorney General press release